Late Night Market

 Night.Owl
 
  Night.Owl
 
Follow  Message
 
 
 
Night.Owl masters market recaps, offering sharp analysis that uncovers hidden patterns and key moves. Stay ahead with Night.Owl’s expert insights.
 

•  05 Feb 2026
 

•   AFRM  
   
  0.00%
•   CI  
   
  0.00%
•   CMI  
   
  0.00%
•   COP  
   
  0.00%
•   COTY  
   
  0.00%

$PTON plunged 25.72% on massive volume of more than 90 million shares after a weak holiday quarter rattled confidence. Revenue missed expectations, losses widened beyond forecasts, and the company’s much-hyped product overhaul failed to attract new buyers at higher price points. The surprise CFO exit added another layer of uncertainty. Even though management pointed to improving margins and guided for stronger adjusted EBITDA ahead, investors focused on slowing demand and soft guidance, sending the stock to $4.39 by the close.

$HIMS slipped 3.73% after announcing a compounded semaglutide pill priced at $49, significantly undercutting Novo Nordisk’s branded offering. While the move positions Hims & Hers as an aggressive disruptor in weight loss treatments, the threat of legal action from Novo injected risk into the story. Traders appear cautious, weighing potential growth against regulatory and litigation overhangs.

$GOOG edged down 0.6% after reporting upbeat quarterly earnings, but heavy AI-driven capital expenditures weighed on sentiment. Multiple analysts raised price targets, some as high as $410, highlighting cloud strength and AI expansion. However, broader Nasdaq weakness and investor sensitivity to surging capex kept shares under pressure even as fundamentals remained intact.

$SIRI surged 9.02% after a strong Q4 earnings beat. EPS and revenue both exceeded expectations, with revenue hitting $2.19 billion. The upside surprise reignited bullish momentum in the stock as investors reassessed growth stability and operating leverage heading into 2026.

$EL dropped 19.19% despite beating quarterly estimates after warning that tariffs could shave $100 million off full-year profitability. Even with raised guidance and restructuring progress, the market punished the stock as tariff headwinds overshadowed operational improvements. The decline suggests investors remain highly sensitive to margin risks in consumer discretionary names.

$COTY declined 8.03% following news of a partnership with OpenAI aimed at enhancing its global organizational systems. While the strategic AI angle drew interest, the stock traded lower alongside broader weakness in beauty and consumer names.

$AFRM slipped 4.41% despite posting GAAP EPS of $0.37, beating estimates by $0.10, and revenue of $1.12 billion, topping forecasts by $60 million. Strong guidance and heavy options activity weren’t enough to offset broader market softness, illustrating how even solid reports can struggle in a cautious tape.

$SONY fell 3.06% even after reporting a 22% jump in quarterly profit and lifting its full-year outlook. Strength in its sensor business and a smartphone recovery were positives, but investors locked in gains following the rally into earnings.

$COP declined 2.46% after missing Q4 earnings estimates, posting non-GAAP EPS of $1.02. Lower realized prices offset production gains, and while the company maintained its dividend, the energy sector showed limited tolerance for earnings misses.

$SYM rose 0.56% after outlining Q2 revenue targets between $650 million and $670 million, pointing to accelerating automation-driven margin expansion. The modest gain reflected cautious optimism.

$CRWD fell 9.2% as investors continued to digest slowing revenue growth and valuation concerns. Shares are now down nearly 22% over three months, signaling pressure on high-multiple cybersecurity names.

$CI advanced 4.72% after beating earnings and revenue expectations while benefiting from specialty growth. A finalized FTC settlement involving its pharmacy benefit manager added clarity, though its 2026 outlook came in slightly below consensus.

$CMI fell 10.73% despite solid revenue performance, as investors focused on a $458 million hit tied to its Accelera hydrogen business. Strength in data center demand was overshadowed by concerns about the hydrogen segment pullback.

View All Headlines